Financial Sense Advisors Inc. Sells 65,966 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Financial Sense Advisors Inc. lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 32.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 138,323 shares of the pharmacy operator’s stock after selling 65,966 shares during the quarter. Financial Sense Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $1,291,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in Walgreens Boots Alliance by 2.0% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 67,016 shares of the pharmacy operator’s stock worth $600,000 after purchasing an additional 1,326 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of Walgreens Boots Alliance by 4.4% in the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after acquiring an additional 1,063 shares in the last quarter. Eastern Bank purchased a new stake in shares of Walgreens Boots Alliance during the third quarter valued at approximately $33,000. Elevated Capital Advisors LLC lifted its holdings in Walgreens Boots Alliance by 35.5% during the third quarter. Elevated Capital Advisors LLC now owns 53,605 shares of the pharmacy operator’s stock worth $480,000 after acquiring an additional 14,043 shares during the period. Finally, International Assets Investment Management LLC boosted its position in Walgreens Boots Alliance by 701.3% in the third quarter. International Assets Investment Management LLC now owns 282,619 shares of the pharmacy operator’s stock worth $2,532,000 after purchasing an additional 247,350 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

WBA has been the subject of several research analyst reports. Royal Bank of Canada raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Jefferies Financial Group lowered their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Finally, Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Trading Down 2.4 %

WBA stock opened at $10.79 on Thursday. The stock has a 50-day simple moving average of $10.36 and a two-hundred day simple moving average of $9.71. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.47. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the prior year, the firm posted $0.66 EPS. Walgreens Boots Alliance’s revenue was up 7.6% on a year-over-year basis. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.